The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo
Abstract
Development of a cell therapy for diabetes would be greatly aided by a renewable supply of human beta-cells. Here we show that pancreatic endoderm derived from human embryonic stem (hES) cells efficiently generates glucose-responsive endocrine cells after implantation into mice. Upon glucose stimulation of the implanted mice, human insulin and C-peptide are detected in sera at levels similar to those of mice transplanted with approximately 3,000 human islets. Moreover, the insulin-expressing cells generated after engraftment exhibit many properties of functional beta-cells, including expression of critical beta-cell transcription factors, appropriate processing of proinsulin and the presence of mature endocrine secretory granules. Finally, in a test of therapeutic potential, we demonstrate that implantation of hES cell-derived pancreatic endoderm protects against streptozotocin-induced hyperglycemia. Together, these data provide definitive evidence that hES cells are competent to generate glucose-responsive, insulin-secreting cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, ViaCyte developed a stem cell-derived pancreatic endoderm cell population known as PEC-01, which they demonstrated to mature over several months in vivo into insulin-producing endocrine cells in rodent models.29–31”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [31]
Citations
Cites
Brissova, M., Fowler, M. J., Nicholson, W. E., Chu, A., Hirshberg, B., Harlan, D. M., & Powers, A. C. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5c6684.2005 · Cited by 797
Successful Islet Transplantation
Ryan, E. A., Lakey, J. R. T., Paty, B. W., Imes, S., Korbutt, G. S., Kneteman, N. M., Bigam, D., Rajotte, R. V., & Shapiro, A. M. J. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2148 · Cited by 719
Flagged first, then by citations
Research works printed but not linked: 43
- Lakey, J.R., Mirbolooki, M. & Shapiro, A.M. Current status of clinical islet cell transplantation. Methods Mol. Biol. 333, 47–104 (2006).
- Amit, M. et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271–278 (2000). · DOI
- Rosler, E.S. et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev. Dyn. 229, 259–274 (2004). · DOI
- D'Amour, K.A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534–1541 (2005). · DOI · Paper page
- D'Amour, K.A. et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24, 1392–1401 (2006). · DOI
- Jiang, J. et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25, 1940–1953 (2007). · DOI
- Tuch, B.E., Osgerby, K.J. & Turtle, J.R. Reversal of diabetes in hyperglycaemic nude mice by human fetal pancreas. Transplant. Proc. 21, 2665–2666 (1989).
- Beattie, G.M., Butler, C. & Hayek, A. Morphology and function of cultured human fetal pancreatic cells transplanted into athymic mice: a longitudinal study. Cell Transplant. 3, 421–425 (1994). · DOI
- Hayek, A. & Beattie, G.M. Experimental transplantation of human fetal and adult pancreatic islets. J. Clin. Endocrinol. Metab. 82, 2471–2475 (1997).
- Castaing, M. et al. Blood glucose normalization upon transplantation of human embryonic pancreas into beta-cell-deficient SCID mice. Diabetologia 44, 2066–2076 (2001). · DOI
- Castaing, M., Duvillie, B., Quemeneur, E., Basmaciogullari, A. & Scharfmann, R. Ex vivo analysis of acinar and endocrine cell development in the human embryonic pancreas. Dev. Dyn. 234, 339–345 (2005). · DOI
- Jensen, J. Gene regulatory factors in pancreatic development. Dev. Dyn. 229, 176–200 (2004). · DOI
- Zorn, A.M. & Wells, J.M. Molecular basis of vertebrate endoderm development. Int. Rev. Cytol. 259, 49–111 (2007). · DOI
- Jorgensen, M.C. et al. An illustrated review of early pancreas development in the mouse. Endocr. Rev. 28, 685–705 (2007). · DOI
- Gaber, A.O. et al. Human islet graft function in NOD-SCID mice predicts clinical response in islet transplant recipients. Transplant. Proc. 36, 1108–1110 (2004). · DOI
- Cabrera, O. et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. USA 103, 2334–2339 (2006). · DOI · Paper page
- Guz, Y. et al. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 121, 11–18 (1995). · DOI
- Collombat, P. et al. Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression. J. Clin. Invest. 117, 961–970 (2007). · DOI
- Olbrot, M., Rud, J., Moss, L.G. & Sharma, A. Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc. Natl. Acad. Sci. USA 99, 6737–6742 (2002). · DOI
- Matsuoka, T.A. et al. Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol. Cell. Biol. 23, 6049–6062 (2003). · DOI
- Matsuoka, T.A. et al. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc. Natl. Acad. Sci. USA 101, 2930–2933 (2004). · DOI
- Nishimura, W. et al. A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev. Biol. 293, 526–539 (2006). · DOI
- Artner, I. et al. MafB: an activator of the glucagon gene expressed in developing islet alpha- and beta-cells. Diabetes 55, 297–304 (2006). · DOI
- Zhang, C. et al. MafA is a key regulator of glucose-stimulated insulin secretion. Mol. Cell. Biol. 25, 4969–4976 (2005). · DOI
- Wilson, M.E., Kalamaras, J.A. & German, M.S. Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas. Mech. Dev. 115, 171–176 (2002). · DOI
- Klimstra, D.S. in Histology for Pathologists. (ed. S.S. Sternberg) 613–647 (Lippincott-Raven Publishers, Philadelphia; 1997).
- Marzban, L. et al. Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death. Diabetes 55, 2192–2201 (2006). · DOI
- Okamoto, H. The role of poly(ADP-ribose) synthetase in the development of insulin-dependent diabetes and islet B-cell regeneration. Biomed. Biochim. Acta 44, 15–20 (1985).
- Eizirik, D.L. et al. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc. Natl. Acad. Sci. USA 91, 9253–9256 (1994). · DOI
- Hosokawa, M., Dolci, W. & Thorens, B. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin. Biochem. Biophys. Res. Commun. 289, 1114–1117 (2001). · DOI
- Yang, H. & Wright, J.R., Jr. Human beta cells are exceedingly resistant to streptozotocin in vivo. Endocrinology 143, 2491–2495 (2002). · DOI
- Hering, B.J. et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. J. Am. Med. Assoc. 293, 830–835 (2005). · DOI
- Zertal-Zidani, S., Bounacer, A. & Scharfmann, R. Regulation of pancreatic endocrine cell differentiation by sulphated proteoglycans. Diabetologia 50, 585–595 (2007). · DOI
- Attali, M. et al. Control of beta-cell differentiation by the pancreatic mesenchyme. Diabetes 56, 1248–1258 (2007). · DOI
- Tulachan, S.S. et al. All-trans retinoic acid induces differentiation of ducts and endocrine cells by mesenchymal/epithelial interactions in embryonic pancreas. Diabetes 52, 76–84 (2003). · DOI
- Kobayashi, H. et al. Retinoid signaling controls mouse pancreatic exocrine lineage selection through epithelial-mesenchymal interactions. Gastroenterology 123, 1331–1340 (2002). · DOI
- Tuch, B.E. & Monk, R.S. Regulation of blood glucose to human levels by human fetal pancreatic xenografts. Transplantation 51, 1156–1160 (1991). · DOI
- Tuch, B.E., Jones, A. & Turtle, J.R. Maturation of the response of human fetal pancreatic explants to glucose. Diabetologia 28, 28–31 (1985). · DOI
- Tuch, B.E. Reversal of diabetes by human fetal pancreas. Optimization of requirements in the hyperglycemic nude mouse. Transplantation 51, 557–562 (1991). · DOI
- Fornoni, A. et al. Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 51, 298–308 (2008). · DOI
- Weitgasser, R., Davalli, A.M. & Weir, G.C. Measurement of glucose concentrations in rats: differences between glucose meter and plasma laboratory results. Diabetologia 42, 256 (1999). · DOI
- Joannides, A. et al. Automated mechanical passaging: a novel and efficient method for human embryonic stem cell expansion. Stem Cells 24, 230–235 (2006). · DOI
- Schrot, R.J., Patel, K.T. & Foulis, P. Evaluation of inaccuracies in the measurement of glycemia in the laboratory, by glucose meters, and through measurement of hemoglobin A1c. Clin Diabetes 25, 43–49 (2007). · DOI
Cited by
Sorted by citations
Items 901–1,000 of 1,003
Clinical Applications of Cell Encapsulation Technology
Santos‐Vizcaíno, E., Orive, G., Pedraz, J. L., & Hernández, R. M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0215-7_32 · Cited by 18
Grapin‐Botton, A. (2008) · StemBook · doi:10.3824/stembook.1.30.1 · Cited by 14
“The role of retinoic acid, Fgf10 and the absence of Shh in pancreas development were exploited to enrich endodermalized ES cells in pancreas progenitors (D’Amour et al., 2006; Kroon et al., 2008).”
BackgroundLee, J.-Y., Baek, H., Jang, J., Park, J., Cha, S.-R., Hong, S., Kim, J., Lee, J., Hong, I., Wang, S.-J., et al. (2023) · Toxicology in Vitro · doi:10.1016/j.tiv.2023.105585 · Cited by 15
The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells?
Naqvi, R. A., Naqvi, A. R., Singh, A. R., Priyadarshini, M., Balamurugan, A. N., & Layden, B. T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1001041 · Cited by 15
Mitogen Synergy: An Emerging Route to Boosting Human Beta Cell Proliferation
Shcheglova, E. G., Błaszczyk, K., & Borowiak, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.734597 · Cited by 18
Burgos, J. I., Vallier, L., & Rodríguez‐Seguí, S. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.692596 · Cited by 17
Angiopoietins stimulate pancreatic islet development from stem cells
Karanth, S. S., Sun, S., Bi, H.-J., Ye, K.-M., & Jin, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-92922-5 · Cited by 15
Wszola, M., Nitarska, D., Cywoniuk, P., Gomółka, M., & Klak, M. (2021) · Cells · doi:10.3390/cells10061544 · Cited by 20
“Despite those drawbacks, company ViaCyte performed two clinical studies where hESC pancreatic progenitors [154,157] were transplanted into T1D patients (NCT02239354, NCT03162926).”
BackgroundTriolo, T. M., & Bellin, M. D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.636824 · Cited by 19
Building Biomimetic Potency Tests for Islet Transplantation
Glieberman, A. L., Pope, B. D., Melton, D., & Parker, K. K. (2021) · Diabetes · doi:10.2337/db20-0297 · Cited by 15
“Stem cell therapies have recently become available as a possible alternative source of tissue for transplantation (10,11) and are poised to address the shortage of cadaveric islets by providing an unlimited and controlled source for insulinproducing cells.”
BackgroundLi, X.-Y., Wei, Z.-H., Wu, L., Lv, H., Zhang, Y.-C., Li, J., Yao, H., Zhang, H., Yang, B., Xu, X., et al. (2020) · Biomaterials Science · doi:10.1039/d0bm01076f · Cited by 15
Bukys, M. A., Mihas, A., Finney, K., Sears, K., Trivedi, D., Wang, Y., Oberholzer, J., & Jensen, J. (2020) · iScience · doi:10.1016/j.isci.2020.101346 · Cited by 15
Hoveizi, E., & Mohammadi, T. (2019) · Journal of materials science. Materials in medicine · doi:10.1007/s10856-019-6301-3 · Cited by 15
Farahmand, S., O'Connor, C. D., Macoska, J., & Zarringhalam, K. (2019) · bioRxiv · doi:10.1093/nar/gkz1046 · Cited by 15
“tor cells convert to NKX2-2+ endocrine cells, which are able to further differentiate into fully functional insulin producing cells upon implantation into mice (34).”
BackgroundDupont, G., Yilmaz, E., Loukas, M., Macchi, V., Caro, R. D., & Tubbs, R. S. (2019) · Clinical anatomy (New York, N.Y. Print) · doi:10.1002/ca.23318 · Cited by 15
“In addition to reversing disease, hES cells can infiltrate and replenish damaged regions of organs after implantation, for example, remuscularization of infarcted myocardium, neuronal precursor cells for repairing CNS injury, and regeneration of glucoseresponsive pancreatic tissue (Zhang et al., 2001; Laflamme et al.,…”
BackgroundCota-Coronado, A., Ramírez-Rodríguez, P. B., Padilla‐Camberos, E., Díaz, É. F., Flores-Fernández, J. M., Ávila‐González, D., & Diaz-Martinez, N. E. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.10.001 · Cited by 19
RNA‐Generated and Gene‐Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy
Kehler, J., Greco, M., Martino, V., Manickam, P., Yokoe, H., Chen, A. P., Yang, M., Auerbach, J., Jessee, J. A., Götte, M., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25597 · Cited by 15
“iPSC lines are induced into early endoderm and mesoderm according to published methods (D’Amour et al., 2006; Kroon et al., 2008).”
MethodEthical issues in biomedical use of human embryonic stem cells (hESCs)
Ghosh, D., Mehta, N., Patil, A., & Sengupta, J. (2016) · Journal of Reproductive Health and Medicine · doi:10.1016/j.jrhm.2016.09.002 · Cited by 20
Vieira, A., Courtney, M. L., Druelle, N., Avolio, F., Napolitano, T., Hadzic, B., Sanz, S. N., Ben-Othman, N., & Collombat, P. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12721 · Cited by 12
“to respond to glucose and spontaneously forming clusters after transplantation into mice.(9) These results led the authors to combine this protocol with a new encapsulation device as the basis for the establishment of a currently undergoing phase I/II clinical trial.”
BackgroundMicroRNA dynamics during human embryonic stem cell differentiation to pancreatic endoderm
Fogel, G. B., Kai, Z. S., Zargar, S., Hinton, A. C., Jones, G. A., Wong, A. S., Ficici, S. G., Lopez, A. D., & King, C. C. (2015) · Gene · doi:10.1016/j.gene.2015.08.027 · Cited by 13
The advancement of human pluripotent stem cell-derived therapies into the clinic
Thies, R., & Murry, C. (2015) · Development · doi:10.1242/dev.131250 · Cited by 15
“Their cell production process involves a stepwise protocol utilizing growth factor signaling pathways involved in the normal embryonic development of PDX1+ pancreatic endoderm, which gives rise to β-cells (D’Amour et al., 2005, 2006; Kroon et al., 2008; Schulz et al., 2012).”
BackgroundKhattabi, I. E., & Sharma, A. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.09.006 · Cited by 16
Regenerative Medicine in Diabetes
Matveyenko, A. V., & Vella, A. V. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.01.019 · Cited by 18
The effect of endothelial cells on hESC-derived pancreatic progenitors in a 3D environment.
Weizman, A., Michael, I., Wiesel-Motiuk, N., Rezania, A., & Levenberg, S. (2014) · Biomaterials Science · doi:10.1039/c4bm00304g · Cited by 15
Nair, G. G., Vincent, R. K., & Odorico, J. S. (2013) · Stem Cells · doi:10.1002/stem.1616 · Cited by 13
Katsumata, T., Oishi, H., Sekiguchi, Y., Nagasaki, H., Daassi, D., Tai, P., Ema, M., Kudo, T., & Takahashi, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060411 · Cited by 12
Current status of regeneration of pancreatic β‐cells
Minami, K., & Seino, S. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12062 · Cited by 13
Novel Pancreatic Endocrine Maturation Pathways Identified by Genomic Profiling and Causal Reasoning
Gutteridge, A., Rukstalis, J. M., Ziemek, D., Tié, M., Ji, L., Ramos-Zayas, R., Nardone, N. A., Norquay, L., Brenner, M. B., Tang, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056024 · Cited by 14
“The most successful of these methods succeeded in creating immature human pancreatic endoderm that, when transplanted into a rodent diabetes disease model, matured into functional hormone-producing endocrine tissue and fully restored the normal glycemic state of a diabetic animal [4].”
BackgroundDelaspre, F., Massumi, M., Salido, M., Soria, B., Ravassard, P., Savatier, P., & Skoudy, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054243 · Cited by 14
“instructive signals playing a role in pancreatic organogenesis and b-cell differentiation to commit ESC to similar fates in vitro in order to obtain a source of replaceable b-cells for diabetic patients [5,6,7].”
BackgroundStem cell therapy: an exercise in patience and prudence
Lin, H.-T., Otsu, M., & Nakauchi, H. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0334 · Cited by 52
“What this example highlights is that basic functional tests are sufficient for characterization purposes, but more comprehensive assessments will be necessary, perhaps involving transplantation into an animal host, to predict in vivo functioning [97].”
Size-controlled Insulin Secreting Cell Clusters
Mendelsohn, A., Nyitray, C. E., Sena, M., & Desai, T. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.08.010 · Cited by 15
Ontogenesis of Hepatic and Pancreatic Stem Cells
Burke, Z. D., & Tosh, D. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9350-2 · Cited by 14
Improved differentiation protocol of rat bone marrow precursors to functional islet like cells
Chelluri, L., Kancherla, R., Turlapati, N., Vemuri, S., Debnath, T., Kumar, M., Beevi, S. S., & Kamaraju, R. S. (2011) · doi:10.4081/scs.2011.e5 · Cited by 15
Allsopp, T., Bunnage, M., & Fish, P. (2010) · MedChemComm · doi:10.1039/c0md00055h · Cited by 15
Human pluripotent stem cells: from biology to cell therapy.
Ramirez, J.-M., Bai, Q., Dijon-Grinand, M., Assou, S., Gerbal-Chaloin, S., Hamamah, S., & de Vos, J. (2010) · World Journal of Stem Cells · doi:10.4252/wjsc.v2.i2.24 · Cited by 15
Early Predictive Factors of Inhospital Mortality in Patients With Severe Acute Pancreatitis
Wang, X., Cui, Z., Zhang, J., Li, H., Zhang, D.-P., Miao, B., Cui, Y.-F., Zhao, E.-P., Li, Z.-L., & Cui, N. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181b65dd5 · Cited by 15
Strategies for future histocompatible stem cell therapy
Nehlin, J. O., & Barington, T. (2009) · Biogerontology · doi:10.1007/s10522-009-9213-7 · Cited by 11
“As a follow up of this work, Kroon et al. (2008) generated insulin-producing beta-cells from hESC in vivo after implantation in mice, indicating that the treatment of diabetes type 1 using a stem cell-based therapy appears closer.”
BackgroundThe Role of Epigenetics in Type 1 Diabetes
Xie, Z., Chang, C., Huang, G., & Zhou, Z. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3449-2_9 · Cited by 36
Directed differentiation of human pluripotent stem cells along the pancreatic endocrine lineage.
van Hoof, D., & Liku, M. E. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-348-0_10 · Cited by 15
Stem Cell Therapy to Treat Diabetes Mellitus
Liew, C. G., & Andrews, P. W. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.203 · Cited by 19
Arroyave, F., Uscátegui, Y., & Lizcano, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179654 · Cited by 14
“In this stage, the expression of hnf4a and the preservation of foxA2 and sox17 expression are good indicators of pancreatic gut differentiation (Figure 3A,B) [20,29].”
BackgroundDiané, A., Mohammed, L. I., & Al-Siddiqi, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01171-8 · Cited by 20
“Interestingly, many of these protocols used traditional two-dimensional monolayer tissue cultures, which results in robust generation of PDX1 + / NKX6–1 + pancreatic progenitors that could mature in vivo after transplantation [24].”
BackgroundShilleh, A. H., Beard, S., & Russ, H. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.05.010 · Cited by 14
“Indeed, we and others have reported the formation of unwanted, proliferative structures, some of which present as liquid-filled cysts after transplantation of sBC differentiations (Hentze et al., 2009; Nair et al., 2019; Parent et al., 2022; Aghazadeh et al., 2022; Kelly et al., 2011; Rezania et al., 2012; Motté et al…”
BackgroundInfluentialParis, F., Pizzuti, V., Marrazzo, P., Pession, A., Alviano, F., & Bonsi, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314597 · Cited by 14
Stem cell therapy for insulin-dependent diabetes: Are we still on the road?
Yang, L., Hu, Z.-M., Jiang, F., & Wang, W. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i7.503 · Cited by 21
β cell regeneration and novel strategies for treatment of diabetes (Review).
Ji, Z., Lu, M., Xie, H., Yuan, H.-G., & Chen, Q. (2022) · Biomedical Reports · doi:10.3892/br.2022.1555 · Cited by 14
“However, hiPSC‑derived β cells from T1D patients can be used as an autologous source of cell replacement therapy, thereby eliminating the problem of systemic immunosuppression (28).”
BackgroundInfluentialTran, R., Moraes, C., & Hoesli, C. A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.583970 · Cited by 19
“1+ pancreatic progenitors are transplanted into immunocompromised mice, they form functional insulin-producing cells (Kroon, 2008; Rezania et al., 2012) and are able to provide long-term glycemic control when encapsulated within immunoprotective alginate polymers (Vegas et al., 2016).”
BackgroundKuo, Y.-C., Lee, I.-H., & Rajesh, R. (2019) · Journal of the Taiwan Institute of Chemical Engineers / Elsevier · doi:10.1016/j.jtice.2019.09.010 · Cited by 14
Gere-Becker, M. B., Pommerenke, C., Lingner, T., & Pieler, T. (2018) · Development · doi:10.1242/dev.161372 · Cited by 14
Jiang, F., Li, K., Archer, M., Mehta, M., Jamieson, E. L., CHARLES, A. K., Dickinson, J. E., Matsumoto, M., & Morahan, G. (2017) · Stem Cells · doi:10.1002/stem.2567 · Cited by 15
Luft, S., Arrizabalaga, O., Kulish, I., Nasonova, E., Durante, M., Ritter, S., & Schroeder, I. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0277 · Cited by 14
“Differentiation of MP H9 hES cells into DE was performed in three independent experiments (using cells of passage 64, 66, and 68, respectively) according to reference [18] as depicted in Fig.”
Salguero‐Aranda, C., Tapia‐Limonchi, R., Cahuana, G. M., Hitos, A. B., Diaz, I., Hmadcha, A., Fraga, M. F., Martı́n, F., Soria, B., Tejedo, J. R., et al. (2016) · Cell Transplantation · doi:10.3727/096368916x691178 · Cited by 17
Konorov, S., Schulze, H. G., Gage, B. K., Kieffer, T., Piret, J., Blades, M., & Turner, R. F. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03295 · Cited by 14
Fox, E. K., Shojaie, S., Wang, J., Tseu, I., Ackerley, C. A., Bilodeau, M., & Post, M. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0227 · Cited by 16
“While otherendodermalorgans,suchastheliverandpancreas,have seensuccessinproducingrelativelypurepopulationsofpro-genitorcellscapableofexpansioninculture[5–7],thishasyet tobeachievedinthelung.”
Epigenetic Regulation of Pancreatic Islets
Haumaître, C. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0403-y · Cited by 14
“The development process of β cells from multipotent progenitors can be successfully recapitulated only partially in vitro to generate pancreatic progenitors and functional β cells in cell replacement therapy for treating diabetes [51–53].”
Background[Reprogramming pancreatic cells to β cells].
Vieira, A., Druelle, N., Courtney, M., Avolio, F., Ben-Othman, N., Pfeifer, A., Gjernes, E., Faurite, B., & Collombat, P. (2013) · Medecine sciences : M/S · doi:10.1051/medsci/2013298014 · Cited by 14
“Dans ce dernier cas, de nombreux laboratoires tentent d’induire la genèse de cellules in vitro ou in vivo à partir de différentes sources cellulaires, telles que les cellules souches embryonnaires [24, 25], adultes et/ou induites [5, 6, 24, 25] (➜).”
BackgroundPotential for pharmacological manipulation of human embryonic stem cells
Atkinson, S. P., Lako, M., & Armstrong, L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01978.x · Cited by 13
Stem Cells as a Tool to Improve Outcomes of Islet Transplantation
Sims, E. K., & Evans‐Molina, C. (2012) · Journal of Transplantation · doi:10.1155/2012/736491 · Cited by 12
“Safety concerns have also arisen regarding teratoma formation from undifferentiated cells [69, 109].”
BackgroundKinzer, K. P., Salmon, P., & Oberholzer, J. (2012) · Wiley eBooks · doi:10.1002/9781118498453.ch18 · Cited by 3
Harnessing the potential of induced pluripotent stem cells for regenerative medicine
Wu, S. M., & Hochedlinger, K. (2011) · Nature Cell Biology · doi:10.1038/ncb0511-497 · Cited by 515
“However, researchers have recently succeeded in generating insulin-producing cell”
Huang, C. J., Butler, A. E., Moran, A., Rao, P. N., WAGNER, J. E., Blazar, B. R., RIZZA, R. A., Manivel, J. C., & Butler, P. C. (2011) · Diabetologia · doi:10.1007/s00125-011-2071-2 · Cited by 11
“To make a first estimate of the potential for beta cell replacement through umbilical cord blood cell transplant, if umbilical cord blood cell recipients were to accomplish an increment in beta cells of approximately 2% per treatment, then 25 treatments would be required to establish a beta cell mass of ∼50% of normal…”
Pancreatic islet transplantation
Noguchi, H. (2009) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v1.i1.16 · Cited by 32
Nagase, T., Ueno, M., Matsumura, M., Muguruma, K., Ohgushi, M., Kondo, N., Kanematsu, D., Kanemura, Y., & Sasai, Y. (2009) · Developmental Dynamics · doi:10.1002/dvdy.21944 · Cited by 14
Cell therapy for type 2 diabetes: is it desirable and can we get it?
Halban, P. A. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00957.x · Cited by 10
Fluorescence‐activated cell sorting purification of pancreatic progenitor cells
杉山, 拓., & Kim, S. K. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00954.x · Cited by 12
Bose, B., Katikireddy, K., & Shenoy, P. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800174-5.00009-0 · Cited by 14
Pathways to New CellsPreprint
Zhou, Q., & Melton, D. A. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.72.002 · Cited by 17
“Using a protocol of stepwise differentiation based on conclusions from other studies of normal pancreatic development, significant advances have been made to produce β cells from human ES cells (D’Amour et al. 2005, 2006; Kroon et al. 2008).”
MethodA critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus
Bora, J., Dey, A., Lyngdoh, A. R., Dhasmana, A., Ranjan, A., Kishore, S., Rustagi, S., Tuli, H. S., Chauhan, A. P. S., Rath, P., et al. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02631-1 · Cited by 14
“When transplanted into immune-deficient mice, the endocrine progenitor cells produced by the current differentiation techniques ultimately develop and mature into insulin-secreting beta cells (Kroon et al. 2008; Kelly et al. 2011; Rezania et al. 2012; Rezania et al. 2013).”
BackgroundShilleh, A. H., & Russ, H. A. (2023) · Cells · doi:10.3390/cells12050698 · Cited by 16
Development of a 3D subcutaneous construct containing insulin-producing beta cells using bioprinting
Ahn, C. B., Lee, J., Kim, J. H., Kim, T. H., Jun, H., Son, K. H., & Lee, J. W. (2022) · Bio-Design and Manufacturing · doi:10.1007/s42242-021-00178-9 · Cited by 18
Stem/progenitor cells in normal physiology and disease of the pancreas
Fallas, M. E. A., Pedraza‐Arévalo, S., Cujba, A.-M., Manea, T., Lambert, C., Morrugares, R., & Sancho, R. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111459 · Cited by 16
“Subsequent studies developed better protocols to improve the efficiency of generation and the functionality of β-like cells (Kroon et al., 2008; Pagliuca et al., 2014; Rezania et al., 2014; Rezania et al., 2012; Russ et al., 2015).”
Iworima, D. G., Rieck, S., & Kieffer, T. J. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.21-0161 · Cited by 25
“developing differentiation protocols that yield functionally mature insulin-producing cells.(9,12,24-29) In some cases, PSC-derived insulinproducing cells generated entirely in vitro were capable of glucosestimulated insulin secretion(9,24-26,30) as well as increased calcium signaling and mitochondrial respiration, si…”
BackgroundThe Eye as a Transplantation Site to Monitor Pancreatic Islet Cell Plasticity
Ilegems, E., & Berggren, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.652853 · Cited by 13
Functional, metabolic and transcriptional maturation of stem cell derived beta cells
Balboa, D., Barsby, T., Lithovius, V., Saarimäki-Vire, J., Omar-Hmeadi, M., Dyachok, O., Montaser, H., Lund, P., Yang, M., Ibrahim, H., et al. (2021) · bioRxiv · doi:10.1101/2021.03.31.437748 · Cited by 13
Process development and scale-up of pluripotent stem cell manufacturing
Huang, S. I., Razvi, A., Anderson-Jenkins, Z., Sirskyj, D., Gong, M., Lavoie, A., & Pigeau, G. (2020) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2020.141 · Cited by 13
“The possible applications for these cells are extensive, and their therapeutic potential is being investigated for use in a wide array of clinical areas, including those associated with high morbidity and mortality rates on a global scale, such as heart failure [8,13], Parkinson’s disease [7] and type I diabetes [6,10…”
BackgroundThe Current Status of Bioartificial Pancreas Devices
Photiadis, S. J., Gologorsky, R. C., & Sarode, D. N. (2020) · ASAIO Journal · doi:10.1097/mat.0000000000001252 · Cited by 17
Stem Cell-Based Therapeutic Approaches to Restore Sensorineural Hearing Loss in Mammals
Waqas, M., Us-Salam, I., Bibi, Z., Wang, Y., Li, H., Zhu, Z., & He, S. (2020) · Neural Plasticity · doi:10.1155/2020/8829660 · Cited by 14
Yang, W., Lampe, P., Kensel-Hammes, P., Hesson, J., Ware, C., Crisá, L., & Cirulli, V. (2019) · iScience · doi:10.1016/j.isci.2019.07.033 · Cited by 13
Konagaya, S., & Iwata, H. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.05.012 · Cited by 19
The advancement of human pluripotent stem cell-derived therapies into the clinic
Thies, R., & Murry, C. (2015) · Development · doi:10.1242/dev.126482 · Cited by 13
Tse, H. M., Kozlovskaya, V., Kharlampieva, E., & Hunter, C. S. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1085 · Cited by 15
Stem Cells Therapy in Diabetes Mellitus
Yang, X. (2014) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000199 · Cited by 14
Liu, J., Joglekar, M., Sumer, H., Hardikar, A., Teede, H., & Verma, P. (2014) · Cell Medicine · doi:10.3727/215517914x681785 · Cited by 13
“Endocrine progenitors could be further matured in vivo into insulin-expressing cells after transplantation (6,8) or differentiated in vitro into glucagon-secreting a-cells or insulin-secreting b-cells using small molecules that promote directed differentiation (15,27).”
BackgroundIslet transplantation in type 1 diabetes: hype, hope and reality – a clinician's perspective
Zinger, A., & Leibowitz, G. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2484 · Cited by 13
“sistant to xenorejection [28], human embryonic stem cells [29], induced pluripotent stem cells derived from adult tissues [30], trans-differentiation of hepatocytes [31,32] and pancreatic acinar tissue [33] and expansion of adult”
BackgroundShi, Q., Lees, J. R., Scott, D. W., Färber, D. L., & Bartlett, S. T. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03943.x · Cited by 14
“Moreover, the ALS/PLNC protocol could also be useful in regulating autoimmune responses to islet regeneration approaches that are currently being developed (42,43).”
BackgroundZou, C., Wang, J.-Y., Wang, S.-Y., Huang, F., Ren, Z.-H., Chen, Z.-G., & Zhang, Y. (2012) · Science China Life Sciences · doi:10.1007/s11427-012-4288-9 · Cited by 13
Lie, K. H., Tuch, B., & Sidhu, K. (2012) · Pancreas · doi:10.1097/mpa.0b013e31822362e4 · Cited by 13
“To date, several studies have demonstrated the differentiation of hESC-derived pancreatic progenitors into functional islet-like cells when transplanted into mice.(3,10,11) Following the transplantation of pancreatic epithelium cells under the kidney capsule of nonobese diabetic/severe combined immunodeficient (NOD/SC…”
BackgroundDeclercq, J., Kumar, A., van Diepen, J. A., Vroegrijk, I. O. C. M., Gysemans, C. A., Pietro, C. D., Voshol, P. J., Mathieu, C., Ectors, N., de Ven, W. J. M. V., et al. (2010) · Diabetes · doi:10.2337/db09-1446 · Cited by 12
“In this context, stem cells of both embryonic and adult origin offer interesting perspectives (3).”
Hepatocytes from Induced Pluripotent Stem Cells: A Giant Leap Forward for Hepatology
Gallicano, G., & Mishra, L. (2010) · Hepatology · doi:10.1002/hep.23474 · Cited by 13
Recent advances in stem cell research for the treatment of diabetes.
Noguchi, H. (2009) · World Journal of Stem Cells · doi:10.4252/wjsc.v1.i1.36 · Cited by 13
Specifying mouse embryonic germ cells.
Tam, P., & Loebel, D. (2009) · Cell · doi:10.1016/j.cell.2009.04.016 · Cited by 13
“The most effective approach for achieving this is to recapitulate in vitro the signals that regulate the differentiation of specialized cell types, such as neurons or pancreatic beta cells (Wichterle et al., 2002; Kroon et al., 2008).”
BackgroundPromotion of β-Cell Differentiation in Pancreatic Precursor Cells by Adult Islet Cells
Chen, W., Begum, S., Opare-Addo, L., Garyu, J., Gibson, T. F., Bothwell, A. L. M., Papaioannou, V. E., & Herold, K. C. (2008) · Endocrinology · doi:10.1210/en.2008-1009 · Cited by 12
Modeling spatial distribution of oxygen in 3d culture of islet beta‐cells
Mcreynolds, J., Wen, Y.-C., Li, X.-F., Guan, J., & Jin, S. (2017) · Biotechnology progress (Print) · doi:10.1002/btpr.2395 · Cited by 13
Turning human epidermis into pancreatic endoderm.
Santamaria, P., Rodríguez-Pizá, I., Clemente-Casares, X., Yamanouchi, J., Mulero-Perez, L., Aasen, T., Raya, Á., & Belmonte, J. C. I. (2010) · The review of diabetic studies : RDS · doi:10.1900/rds.2010.7.158 · Cited by 13
“More recently, it has been shown that hES cells can be differentiated into pancreatic endoderm and, much less efficiently, into clusters containing insulin-producing cells [7-13].”
BackgroundMethodResultInfluentialApplication and challenge of pancreatic organoids in therapeutic research
Chen, J., Lu, J., Wang, S., & Miao, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1366417 · Cited by 12
TMEM219 regulates the transcription factor expression and proliferation of beta cells
D’Addio, F., Assi, E., Maestroni, A., Rossi, G., Usuelli, V., Petrazzuolo, A., Nardini, M., Loretelli, C., Nasr, M. B., & Fiorina, P. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1306127 · Cited by 12
“Differentiation to stage 5 was performed as previously described (16, 17).”
MethodThe Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes
Takahashi, F., Patel, P., Kitsuka, T., & Arai, K. (2023) · Bioengineering · doi:10.3390/bioengineering10020237 · Cited by 13
Three-dimensional bioprinting of functional β-islet-like constructs
Parvaneh, S., Kemény, L. V., Ghaffarinia, A., Yarani, R., & Veréb, Z. (2023) · International Journal of Bioprinting · doi:10.18063/ijb.v9i2.665 · Cited by 18
“Kroon et al.[171] showed that pancreatic endoderm derived from hESCs could secrete insulin in response to glucose, even in vivo in STZ-induced hyperglycemia.”
BackgroundCDK8/19 inhibition plays an important role in pancreatic β-cell induction from human iPSCs
Sakuma, K., Tsubooka-Yamazoe, N., Hashimoto, K., Sakai, N., Asano, S., Watanabe-Matsumoto, S., Watanabe, T., Saito, B., Matsumoto, H., Ueno, H., et al. (2023) · Stem cell research & therapeutics · doi:10.1186/s13287-022-03220-4 · Cited by 12
Huang, Y. H., Xu, Y. Y., Zhu, J., Wan, J., Xiong, Y., Jiang, Z., Zhu, S., Guo, Q., Li, Y., Lu, Y., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121882 · Cited by 13
Metadata
- Authors
- Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., Agulnick, A. D., D'Amour, K. A., Carpenter, M. K., & Baetge, E. E.
- Venue
- Nature Biotechnology
- Published
- 2008-02-20
- Volume
- 26
- Issue
- 4
- Pages
- 443-452
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2106219965
- Cited by
- 1,843
- References
- 0
- Citations by year
- 2026: 26 · 2025: 44 · 2024: 46 · 2023: 88 · 2022: 67 · 2021: 81 · 2020: 85 · 2019: 76 · 2018: 87 · 2017: 98 · 2016: 122 · 2015: 116 · 2014: 156 · 2013: 168 · 2012: 154
- FWCI
- 150.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- human embryonic stem cells, beta cell differentiation, glucose-dependent insulin secretion, islet transplantation, diabetes cell therapy, C-peptide, proinsulin processing, streptozotocin-induced hyperglycemia
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Endoderm, Glucose, Humans, Insulin, Cell Culture Techniques, Pancreas, Artificial, Tissue Engineering, Cell Proliferation, Insulin-Secreting Cells, Mice, Embryonic Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review